{
  "case_id": "case_0003",
  "provider": "openai",
  "status": "processed",
  "patient_demographics": {
    "age": 41.24,
    "sex": "Female",
    "genderIdentity": "Transgender Male",
    "ancestry": "European"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesions involving:\n- left optic nerve (cranial nerve II) and left midbrain.\n  \nRemaining signs are better explained by:\n- right medulla lesion\n\nThan the suggested:\n- cervical spinal cord.",
      "structured_data": {
        "gt_lesions_english": [
          "left midbrain",
          "right medulla",
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "Optic Nerve",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "Midbrain",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "Cervical Spinal Cord",
            "side": null,
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)",
          "left midbrain"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [
          "right medulla"
        ],
        "additional_lesions_in_ft": [
          "Cervical Spinal Cord"
        ]
      },
      "scoring": {
        "gt_lesion_count": 3,
        "correctly_identified_count": 2,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 1,
        "additional_lesion_count": 1,
        "proportion_correct": 0.6666666666666666,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.3333333333333333,
        "proportion_additional": 0.3333333333333333
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included: Multiple sclerosis\n  \nThese suggested differentials are reasonable:\n\n- Posterior Communicating Artery Aneurysm causing left CN III palsy; Neuromyelitis Optica Spectrum Disorder; MOG Antibody\u2013Associated Disease; Orbital Apex/Cavernous Sinus Syndrome (e.g., Tolosa\u2013Hunt, cavernous sinus thrombosis); Neurosarcoidosis; Primary CNS Vasculitis (including SLE/ANCA-associated); Degenerative Cervical Myelopathy",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Multiple Sclerosis (relapsing\u2013remitting)",
          "Posterior Communicating Artery Aneurysm causing left CN III palsy",
          "Neuromyelitis Optica Spectrum Disorder",
          "MOG Antibody\u2013Associated Disease",
          "Orbital Apex/Cavernous Sinus Syndrome (e.g., Tolosa\u2013Hunt, cavernous sinus thrombosis)",
          "Neurosarcoidosis",
          "Primary CNS Vasculitis (including SLE/ANCA-associated)",
          "Degenerative Cervical Myelopathy"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Pelvic organ prolapse": "comorbidity",
          "Solar keratosis": "comorbidity"
        },
        "correctly_mentioned": [
          "Multiple sclerosis"
        ],
        "missing_diagnoses": [
          "Pelvic organ prolapse",
          "Solar keratosis"
        ],
        "additional_diagnoses": [
          "Posterior Communicating Artery Aneurysm causing left CN III palsy",
          "Neuromyelitis Optica Spectrum Disorder",
          "MOG Antibody\u2013Associated Disease",
          "Orbital Apex/Cavernous Sinus Syndrome (e.g., Tolosa\u2013Hunt, cavernous sinus thrombosis)",
          "Neurosarcoidosis",
          "Primary CNS Vasculitis (including SLE/ANCA-associated)",
          "Degenerative Cervical Myelopathy"
        ]
      },
      "scoring": {
        "ms_included": 1,
        "incidental_total_count": 0,
        "incidental_missing_count": 0,
        "incidental_missing_proportion": null,
        "comorbidity_total_count": 0,
        "comorbidity_missing_count": 0,
        "comorbidity_missing_proportion": null
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\nAgree with all suggestions.\n\n- MRI including the Brain and Orbits and CSF test for Oligoclonal Bands would potentially inform a diagnosis of multiple sclerosis.",
      "structured_data": {
        "gt_required_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "CT Angiogram Head (Circle of Willis) \u2013 urgent",
          "MRI Brain and Orbits with gadolinium",
          "MRI Cervical Spine with gadolinium",
          "Visual evoked potentials",
          "Optical coherence tomography (OCT)",
          "CSF opening pressure",
          "CSF cell count and differential",
          "CSF protein",
          "CSF glucose",
          "CSF oligoclonal bands with paired serum",
          "CSF culture and viral PCR panel",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Thyroid-stimulating hormone",
          "Vitamin B12",
          "Folate",
          "HbA1c",
          "Serum ACE",
          "ANA",
          "ENA panel",
          "Anti-dsDNA antibodies",
          "ANCA",
          "Aquaporin-4 IgG (serum)",
          "MOG IgG (serum)",
          "HIV serology",
          "Syphilis serology (RPR/TPPA)"
        ],
        "found_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests": []
      },
      "scoring": {
        "gt_tests_count": 3,
        "found_tests_count": 3,
        "missing_tests_count": 0,
        "proportion_found": 1.0,
        "proportion_missing": 0.0
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Appropriate decision to consider but delay treatment.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (Urine: Leucocytes ++, Blood +).\n\n- Presenting complaint is not specified, so no indication whether this is related to MS.\n\n- Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.\n\nDMTs: Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (Urine: Leucocytes ++, Blood +).\n\n- Need a pregnancy test result.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Hospital admission with frequent neurological observations and fall precautions",
            "timing": "Start Now",
            "reasons": [
              "Risk of neurological deterioration",
              "Unsteady gait with spasticity",
              "Facilitates urgent imaging and multidisciplinary input"
            ]
          },
          {
            "treatment": "Corneal protection (lubricating drops/ointment; eye patch if exposure)",
            "timing": "Start Now",
            "reasons": [
              "Severe left ptosis/ophthalmoplegia risks exposure keratopathy",
              "Symptomatic relief of diplopia if present"
            ]
          },
          {
            "treatment": "Mechanical venous thromboembolism prophylaxis (intermittent pneumatic compression)",
            "timing": "Start Now",
            "reasons": [
              "Reduced mobility from spastic paraparesis",
              "Avoids anticoagulation before excluding aneurysm"
            ]
          },
          {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Delay",
            "reasons": [
              "Start after CTA/MRA excludes aneurysm and infection",
              "Treats suspected inflammatory demyelinating relapse",
              "Best efficacy when started within 14 days of relapse"
            ]
          },
          {
            "treatment": "Endovascular coiling or surgical clipping of a posterior communicating artery aneurysm (if confirmed)",
            "timing": "Delay",
            "reasons": [
              "Initiate immediately once aneurysm is identified on urgent angiography",
              "Prevents rupture and treats compressive third-nerve palsy"
            ]
          },
          {
            "treatment": "Physiotherapy and gait/balance rehabilitation",
            "timing": "Start Now",
            "reasons": [
              "Improves mobility and reduces falls",
              "Addresses spasticity and ataxic gait early"
            ]
          },
          {
            "treatment": "Oral baclofen titration for spasticity",
            "timing": "Delay",
            "reasons": [
              "Introduce after acute diagnostic phase",
              "Adjust based on response and side effects"
            ]
          },
          {
            "treatment": "Long-term disease-modifying therapy for MS (agent based on MRI/CSF and risk profile, e.g., ocrelizumab or natalizumab)",
            "timing": "Delay",
            "reasons": [
              "Start only after diagnostic confirmation and exclusion of mimics",
              "Requires baseline screening and counselling"
            ]
          },
          {
            "treatment": "Proton pump inhibitor and bone protection while on high-dose steroids",
            "timing": "Delay",
            "reasons": [
              "Begin when steroids are initiated",
              "Reduces gastrointestinal and bone-related adverse effects"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-dose intravenous methylprednisolone 1 g daily for 3\u20135 days",
            "timing": "Delay",
            "reasons": [
              "Start after CTA/MRA excludes aneurysm and infection",
              "Treats suspected inflammatory demyelinating relapse",
              "Best efficacy when started within 14 days of relapse"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint is not specified, so no indication whether this is related to MS.",
                "Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit."
              ],
              "contraindications": [
                "Evidence of potential active intercurrent infection (Urine: Leucocytes ++, Blood +)."
              ]
            }
          },
          "evaluation_summary": "Appropriate decision to consider but delay treatment.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (Urine: Leucocytes ++, Blood +).\n\n- Presenting complaint is not specified, so no indication whether this is related to MS.\n\n- Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Long-term disease-modifying therapy for MS (agent based on MRI/CSF and risk profile, e.g., ocrelizumab or natalizumab)",
            "timing": "Delay",
            "reasons": [
              "Start only after diagnostic confirmation and exclusion of mimics",
              "Requires baseline screening and counselling"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Need a pregnancy test result."
              ],
              "contraindications": [
                "Evidence of potential active intercurrent infection (Urine: Leucocytes ++, Blood +)."
              ]
            }
          },
          "evaluation_summary": "Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n  \nAdditional factors not mentioned:\n\n- Evidence of potential active intercurrent infection (Urine: Leucocytes ++, Blood +).\n\n- Need a pregnancy test result."
        }
      },
      "scoring": {
        "steroids": {
          "decision_safety": 0,
          "gt_reasons_count": 3,
          "acknowledged_reasons_count": 0,
          "missed_reasons_count": 3,
          "proportion_reasons_acknowledged": 0.0,
          "proportion_reasons_missed": 1.0
        },
        "dmt": {
          "decision_safety": 0,
          "gt_reasons_count": 3,
          "acknowledged_reasons_count": 1,
          "missed_reasons_count": 2,
          "proportion_reasons_acknowledged": 0.3333333333333333,
          "proportion_reasons_missed": 0.6666666666666666
        }
      }
    }
  }
}